Combo inhaler lacks evidence for first-line use in asthma: PBAC
The committee has revealed why it refused to fund budesonide-formoterol for mild asthma
This story has been updated to reinforce that Symbicort remains TGA-listed for mild asthma, despite not being PBS-listed.
Despite new international guidelines recommending combination budesonide-formoterol as first-line for mild asthma, the PBAC says there is a lack of evidence for such advice.
